Apollo Hospitals Want Private Market for Vaccine: Managing Director of Apollo 

Sunita Reddy, the managing director of Apollo hospitals, told Bloomberg that she expects a private market for vaccines by march. She feels that the “government vaccination targets are quite accomplishable, but public and private have to shake hands for the better results. If we achieve this, we will be prepared for the second wave of covid, she added.” 

Apollo hospital enterprises Ltd. is assisting the Indian government in providing vaccines to the front-line workers, as a part of a nationwide vaccine drive. 

Managing director Sunita Reddy has revealed that the operator has trained 6,000 people and allotted 3,500 websites for the augmentation of the immunization campaign. 

Our expectation is up to a month of March, she further said. She believes that there is so much advantage of manufacturing in India, and also the country has great potential to achieve the targets, she said in an interview on Wednesday on Bloomberg television.  

Around 8.6 million of the population have received the vaccination so far, and currently, the fall in covid cases and continuous campaigns are quite appreciable. But the country may fall short of its target to immunize quarter by August. Although there is a substantial fall in the covid cases since the past few months, delay in vaccination may cause the people susceptible to the variant strain. 

The Indian government has prioritized the health care workers for the first shot, after then people above 50 will be receiving it.  

Apollo announced last year about its manufacturing of vaccines to the customers, via the app and convinced them that “they will be the first to know about it” when vaccines will be prepared. 

It is achievable but the public and private sectors have to work together to exceed the number of vaccines administered per day, according to the managing director. 

In the flow of the river of vaccine production, a lot of Indian developers want to dip in. They want to retrieve their costs in the private market. The serum institute of India Ltd. who has the license to produce 1 billion doses of AstraZeneca plc’s vaccine, has disclosed their strategy to sell the vaccine 5 times as the government charged.


Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: